Minimal residual disease and circulating tumor cells in breast cancer

[Recent Results in Cancer Research] Mini

[Recent Results in Cancer Research] Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer Volume 195 || Circulating DNA and Next-Generation Sequencing

✍ Ignatiadis, Michail; Sotiriou, Christos; Pantel, Klaus 📂 Article 📅 2012 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 221 KB

This important book provides up-to-date information on a series of topical issues relating to the approach to minimal residual disease in breast cancer patients. It first explains how the study of minimal residual disease and circulating and disseminated tumor cells (CTCs/DTCs) can assist in the und

[Recent Results in Cancer Research] Mini

[Recent Results in Cancer Research] Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer Volume 195 || DTCs in Breast Cancer: Clinical Research and Practice

✍ Ignatiadis, Michail; Sotiriou, Christos; Pantel, Klaus 📂 Article 📅 2012 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 194 KB

This important book provides up-to-date information on a series of topical issues relating to the approach to minimal residual disease in breast cancer patients. It first explains how the study of minimal residual disease and circulating and disseminated tumor cells (CTCs/DTCs) can assist in the und

[Recent Results in Cancer Research] Mini

[Recent Results in Cancer Research] Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer Volume 195 || Size-Based Enrichment Technologies for CTC Detection and Characterization

✍ Ignatiadis, Michail; Sotiriou, Christos; Pantel, Klaus 📂 Article 📅 2012 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 337 KB

This important book provides up-to-date information on a series of topical issues relating to the approach to minimal residual disease in breast cancer patients. It first explains how the study of minimal residual disease and circulating and disseminated tumor cells (CTCs/DTCs) can assist in the und

Minimal Residual Disease in Breast Cance

Minimal Residual Disease in Breast Cancer

✍ Gunnar Kvalheim; Bjørn Naume; Jahn M. Nesland 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 91 KB

Circulating Tumor Cells, Disease Progres

Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

✍ Massimo Cristofanilli 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Tumor–antigen heterogeneity of dissemina

Tumor–antigen heterogeneity of disseminated breast cancer cells: Implications for immunotherapy of minimal residual disease

✍ Stephan Braun; Florian Hepp; Harald L. Sommer; Klaus Pantel 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 112 KB 👁 1 views

Single micrometastatic tumor cells encased in mesenchymal tissues, such as bone marrow (BM), are regarded as suitable targets for adjuvant immunotherapy since they are easily accessible for both immunoglobulins and immune effector cells. However, the antigen profile of such cells, to which antibody